Acarbose
Acarbose Tablets, USP
Approved
Approval ID
067c0adc-7322-489d-9baa-1d061b37be36
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 30, 2023
Manufacturers
FDA
Bryant Ranch Prepack
DUNS: 171714327
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Acarbose
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code71335-9725
Application NumberANDA202271
Product Classification
M
Marketing Category
C73584
G
Generic Name
Acarbose
Product Specifications
Route of AdministrationORAL
Effective DateMarch 24, 2022
FDA Product Classification
INGREDIENTS (5)
ACARBOSEActive
Quantity: 50 mg in 1 1
Code: T58MSI464G
Classification: ACTIB
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT